| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.747 | 0.005 | 0.747 | Nootropic | 0.236 0.121 CID_115104 0.441 0.029 CID_85785449 | ||
| 0.46 | 0.038 | 0.46 | GABA C receptor rho-3 antagonist | 0.244 0.159 CID_115104 0.343 0.09 CID_85785449 | ||
| 0.411 | 0.052 | 0.411 | MAP kinase kinase 6 inhibitor | 0.244 0.198 CID_115104 0.333 0.106 CID_85785449 | ||
| 0.338 | 0.012 | 0.338 | Protein kinase (CK1) gamma inhibitor | 0.187 0.049 CID_85785449 | ||
| 0.328 | 0.005 | 0.328 | Activin receptor-like kinase 4 inhibitor | 0.189 0.016 CID_115104 0.186 0.017 CID_85785449 | ||
| 0.334 | 0.013 | 0.334 | Lck kinase inhibitor | 0.121 0.084 CID_115104 0.162 0.058 CID_85785449 | ||
| 0.333 | 0.015 | 0.333 | Protein kinase (CK1) gamma 1 inhibitor | 0.165 0.058 CID_85785449 | ||
| 0.321 | 0.005 | 0.321 | Beta amyloid protein antagonist | 0.121 0.066 CID_115104 0.146 0.044 CID_85785449 | ||
| 0.3 | 0.013 | 0.3 | Toll-Like receptor 9 antagonist | |||
| 0.296 | 0.011 | 0.296 | TRKB antagonist | 0.126 0.066 CID_85785449 | ||
| 0.326 | 0.042 | 0.371 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.371 0.031 CID_85785449 | CID_85785449 | |
| 0.321 | 0.045 | 0.355 | Dyrk kinase inhibitor | 0.355 0.036 CID_85785449 | CID_85785449 | |
| 0.307 | 0.034 | 0.307 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.287 0.04 CID_85785449 | ||
| 0.344 | 0.073 | 0.344 | Angiogenesis inhibitor | 0.325 0.081 CID_115104 | ||
| 0.302 | 0.034 | 0.302 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.251 0.045 CID_85785449 | ||
| 0.359 | 0.096 | 0.578 | Histamine release inhibitor | 0.578 0.012 CID_85785449 | CID_85785449 | |
| 0.29 | 0.032 | 0.29 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.307 | 0.05 | 0.307 | Antiamyloidogenic | |||
| 0.272 | 0.022 | 0.272 | Protein kinase (CK1) gamma 3 inhibitor | 0.168 0.071 CID_85785449 | ||
| 0.284 | 0.034 | 0.284 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.215 0.126 CID_115104 | ||
| 0.287 | 0.042 | 0.287 | Clk dual-specificity kinase inhibitor | 0.216 0.07 CID_85785449 | ||
| 0.253 | 0.02 | 0.253 | Protein kinase (CK1) gamma 2 inhibitor | 0.12 0.065 CID_85785449 | ||
| 0.282 | 0.054 | 0.282 | HERG channel blocker | |||
| 0.266 | 0.043 | 0.266 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.21 0.062 CID_85785449 | ||
| 0.242 | 0.023 | 0.242 | Ribosomal protein S6 kinase inhibitor | 0.113 0.099 CID_85785449 | ||
| 0.262 | 0.043 | 0.262 | TRKC antagonist | |||
| 0.253 | 0.035 | 0.253 | Src kinase inhibitor | 0.187 0.061 CID_115104 0.116 0.112 CID_85785449 | ||
| 0.267 | 0.052 | 0.267 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.201 0.074 CID_85785449 | ||
| 0.261 | 0.051 | 0.261 | EphB2 antagonist | |||
| 0.294 | 0.085 | 0.297 | Immunomodulator | 0.297 0.084 CID_85785449 | CID_85785449 | |
| 0.226 | 0.021 | 0.226 | Protein kinase (CK1) delta inhibitor | 0.115 0.077 CID_85785449 | ||
| 0.25 | 0.049 | 0.25 | RNA-directed DNA polymerase inhibitor | 0.238 0.058 CID_85785449 | ||
| 0.241 | 0.043 | 0.241 | LIM domain kinase 1 inhibitor | 0.139 0.11 CID_85785449 | ||
| 0.244 | 0.048 | 0.244 | CDC-like kinase 4 inhibitor | 0.143 0.106 CID_85785449 | ||
| 0.221 | 0.027 | 0.243 | CDC-like kinase 1 inhibitor | 0.243 0.02 CID_85785449 | CID_85785449 | |
| 0.194 | 0.007 | 0.194 | Toll-Like receptor 3 antagonist | 0.129 0.023 CID_85785449 | ||
| 0.192 | 0.011 | 0.192 | Folate antagonist | 0.19 0.012 CID_85785449 | ||
| 0.216 | 0.042 | 0.216 | Protein kinase C nu inhibitor | 0.124 0.089 CID_85785449 | ||
| 0.182 | 0.012 | 0.182 | Phosphodiesterase I inhibitor | 0.098 0.047 CID_115104 0.092 0.056 CID_85785449 | ||
| 0.206 | 0.038 | 0.206 | Protein kinase (CK1) inhibitor | 0.117 0.094 CID_85785449 | ||
| 0.221 | 0.054 | 0.299 | Peroxidase inhibitor | 0.136 0.087 CID_115104 0.299 0.038 CID_85785449 | CID_85785449 | |
| 0.207 | 0.041 | 0.207 | Polo-like kinase-3 inhibitor | 0.161 0.073 CID_85785449 | ||
| 0.17 | 0.005 | 0.17 | Transforming growth factor antagonist | 0.099 0.022 CID_115104 0.109 0.017 CID_85785449 | ||
| 0.179 | 0.016 | 0.179 | Gastric antisecretory | 0.106 0.058 CID_115104 | ||
| 0.233 | 0.073 | 0.233 | Cyclic AMP phosphodiesterase inhibitor | 0.177 0.114 CID_85785449 | ||
| 0.171 | 0.025 | 0.171 | Fibroblast growth factor 1 antagonist | 0.145 0.033 CID_115104 | ||
| 0.206 | 0.063 | 0.206 | CDC-like kinase 2 inhibitor | 0.188 0.073 CID_85785449 | ||
| 0.148 | 0.006 | 0.148 | Toll-Like receptor 7 antagonist | 0.066 0.05 CID_85785449 | ||
| 0.246 | 0.104 | 0.246 | Hypoxia-inducible factor 1 alpha inhibitor | 0.203 0.148 CID_85785449 | ||
| 0.153 | 0.014 | 0.153 | Raf kinase C inhibitor | |||
| 0.162 | 0.025 | 0.162 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.098 0.055 CID_115104 | ||
| 0.182 | 0.046 | 0.182 | Activin receptor-like kinase 2 inhibitor | |||
| 0.321 | 0.186 | 0.321 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.303 0.208 CID_85785449 | ||
| 0.147 | 0.015 | 0.147 | Histamine N-methyltransferase inhibitor | 0.12 0.03 CID_85785449 | ||
| 0.215 | 0.084 | 0.215 | MAP kinase kinase 3 inhibitor | 0.193 0.144 CID_85785449 | ||
| 0.179 | 0.053 | 0.179 | Growth factor antagonist | 0.113 0.1 CID_115104 | ||
| 0.157 | 0.034 | 0.157 | Granulocyte macrophage colony stimulating factor antagonist | |||
| 0.177 | 0.054 | 0.177 | Protein-tyrosine kinase Lyn inhibitor | |||
| 0.21 | 0.089 | 0.21 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.193 | 0.071 | 0.193 | Tyrosine kinase inhibitor | |||
| 0.138 | 0.017 | 0.138 | Macrophage colony-stimulating factor 1 receptor antagonist | |||
| 0.142 | 0.022 | 0.205 | Porphobilinogen synthase inhibitor | 0.069 0.057 CID_115104 0.205 0.012 CID_85785449 | CID_85785449 | |
| 0.123 | 0.009 | 0.123 | Secretase beta inhibitor | 0.066 0.057 CID_85785449 | ||
| 0.133 | 0.019 | 0.133 | Adenosine A2 receptor antagonist | |||
| 0.215 | 0.101 | 0.298 | DNA synthesis inhibitor | 0.298 0.044 CID_85785449 | CID_85785449 | |
| 0.195 | 0.084 | 0.195 | Pyruvate kinase inhibitor | 0.18 0.093 CID_85785449 | ||
| 0.193 | 0.082 | 0.193 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.191 0.084 CID_85785449 | ||
| 0.166 | 0.056 | 0.166 | Tyrosine-protein kinase receptor antagonist | |||
| 0.145 | 0.036 | 0.145 | DNA repair enzyme inhibitor | 0.122 0.069 CID_85785449 | ||
| 0.157 | 0.051 | 0.157 | Toll-Like receptor antagonist | |||
| 0.125 | 0.019 | 0.125 | Adenosine A2a receptor antagonist | |||
| 0.13 | 0.025 | 0.236 | Platelet growth factor antagonist | 0.236 0.006 CID_115104 0.086 0.051 CID_85785449 | CID_115104 | |
| 0.137 | 0.033 | 0.137 | Insulin receptor antagonist | 0.111 0.049 CID_115104 | ||
| 0.121 | 0.019 | 0.121 | Adenosine A1 receptor antagonist | 0.055 0.043 CID_85785449 | ||
| 0.124 | 0.022 | 0.124 | Fibroblast growth factor 3 antagonist | |||
| 0.115 | 0.014 | 0.115 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.183 | 0.085 | 0.183 | Death-associated protein kinase 3 inhibitor | 0.164 0.103 CID_85785449 | ||
| 0.13 | 0.033 | 0.13 | Interleukin 2 antagonist | 0.106 0.074 CID_85785449 | ||
| 0.122 | 0.025 | 0.122 | Raf kinase inhibitor | 0.08 0.045 CID_115104 | ||
| 0.146 | 0.052 | 0.146 | TRKA antagonist | |||
| 0.109 | 0.016 | 0.109 | Transforming growth factor beta 3 antagonist | 0.079 0.069 CID_115104 0.083 0.054 CID_85785449 | ||
| 0.119 | 0.026 | 0.119 | Glutamate (mGluR) antagonist | |||
| 0.106 | 0.014 | 0.106 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.102 | 0.013 | 0.102 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.077 0.044 CID_115104 0.09 0.022 CID_85785449 | ||
| 0.187 | 0.101 | 0.187 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.119 | 0.034 | 0.119 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | |||
| 0.117 | 0.033 | 0.117 | Pim-3 kinase inhibitor | |||
| 0.089 | 0.008 | 0.089 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.193 | 0.113 | 0.193 | MAP-kinase-activated kinase 5 inhibitor | 0.174 0.141 CID_85785449 | ||
| 0.151 | 0.072 | 0.151 | GABA C receptor rho-2 antagonist | 0.14 0.089 CID_85785449 | ||
| 0.127 | 0.049 | 0.166 | Ferrochelatase inhibitor | 0.166 0.032 CID_85785449 | CID_85785449 | |
| 0.105 | 0.028 | 0.105 | Phosphodiesterase XI inhibitor | |||
| 0.105 | 0.028 | 0.105 | Phosphodiesterase 11A inhibitor | |||
| 0.108 | 0.032 | 0.108 | Bromodomain-containing protein 2 inhibitor | |||
| 0.088 | 0.014 | 0.088 | Phosphodiesterase 1C inhibitor | 0.064 0.039 CID_115104 | ||
| 0.107 | 0.033 | 0.12 | Glutamate release inhibitor | 0.12 0.022 CID_85785449 | CID_85785449 | |
| 0.098 | 0.025 | 0.098 | Fibroblast growth factor 2 antagonist | |||
| 0.086 | 0.014 | 0.086 | Phosphodiesterase 1A inhibitor | |||
| 0.097 | 0.027 | 0.141 | Phenylalanine 4-hydroxylase inhibitor | 0.064 0.052 CID_115104 0.141 0.013 CID_85785449 | CID_85785449 | |
| 0.111 | 0.041 | 0.111 | mTOR complex 1 inhibitor | |||
| 0.097 | 0.027 | 0.097 | Glutamate (mGluR group I) antagonist | |||
| 0.12 | 0.052 | 0.132 | Protein kinase C gamma inhibitor | 0.132 0.044 CID_85785449 | CID_85785449 | |
| 0.175 | 0.107 | 0.175 | Histone acetyltransferase inhibitor | |||
| 0.083 | 0.016 | 0.083 | Phosphodiesterase II inhibitor | |||
| 0.135 | 0.069 | 0.135 | Phosphodiesterase inhibitor | |||
| 0.088 | 0.022 | 0.088 | Tyrosine-protein kinase EMT inhibitor | |||
| 0.233 | 0.167 | 0.233 | Calcium channel activator | |||
| 0.147 | 0.082 | 0.147 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.083 | 0.019 | 0.084 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.084 0.019 CID_85785449 | CID_85785449 | |
| 0.078 | 0.014 | 0.078 | Phosphodiesterase X inhibitor | |||
| 0.078 | 0.014 | 0.078 | Phosphodiesterase 10A inhibitor | |||
| 0.109 | 0.047 | 0.109 | Phosphodiesterase 7B inhibitor | |||
| 0.077 | 0.016 | 0.077 | Transforming growth factor beta 1 antagonist | |||
| 0.114 | 0.053 | 0.114 | Check point kinase 2 inhibitor | |||
| 0.067 | 0.008 | 0.067 | Cytokine production stimulant | 0.046 0.04 CID_85785449 | ||
| 0.066 | 0.007 | 0.066 | Potassium channel small-conductance Ca-activated activator | 0.035 0.018 CID_115104 | ||
| 0.075 | 0.016 | 0.075 | Phosphodiesterase 2A inhibitor | |||
| 0.064 | 0.008 | 0.064 | Dihydrofolate reductase inhibitor | 0.048 0.022 CID_85785449 | ||
| 0.078 | 0.023 | 0.078 | Phosphatidylinositol 3-kinase alpha inhibitor | |||
| 0.118 | 0.064 | 0.154 | Interleukin 8 antagonist | 0.154 0.031 CID_85785449 | CID_85785449 | |
| 0.111 | 0.057 | 0.111 | CDC-like kinase 3 inhibitor | 0.099 0.081 CID_85785449 | ||
| 0.066 | 0.014 | 0.066 | Histamine H4 receptor antagonist | |||
| 0.09 | 0.04 | 0.09 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.092 | 0.044 | 0.092 | mTOR complex 2 inhibitor | |||
| 0.077 | 0.029 | 0.077 | Phosphatidylinositol kinase inhibitor | |||
| 0.166 | 0.119 | 0.166 | Potassium channel blocker | |||
| 0.066 | 0.02 | 0.066 | H+/K+-transporting ATPase inhibitor | |||
| 0.072 | 0.025 | 0.072 | Potassium channel (Ca-activated) blocker | |||
| 0.061 | 0.015 | 0.061 | Glutamate (mGluR1a) antagonist | |||
| 0.067 | 0.021 | 0.067 | Histamine agonist | |||
| 0.082 | 0.037 | 0.082 | MAP kinase 7 inhibitor | |||
| 0.112 | 0.068 | 0.112 | Glycogen synthase kinase-3 inhibitor | |||
| 0.099 | 0.056 | 0.099 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | |||
| 0.075 | 0.032 | 0.075 | Raf kinase B inhibitor | 0.051 0.049 CID_115104 | ||
| 0.074 | 0.032 | 0.074 | 5 Hydroxytryptamine 3 agonist | |||
| 0.112 | 0.071 | 0.112 | Aurora-B kinase inhibitor | |||
| 0.08 | 0.04 | 0.08 | Purinergic P2X2 antagonist | |||
| 0.056 | 0.017 | 0.056 | Histamine H2 receptor agonist | |||
| 0.088 | 0.049 | 0.088 | Histamine H2 receptor antagonist | |||
| 0.096 | 0.056 | 0.096 | Protein kinase C zeta inhibitor | 0.089 0.068 CID_85785449 | ||
| 0.047 | 0.008 | 0.047 | Transforming growth factor beta 2 antagonist | 0.031 0.03 CID_115104 0.033 0.024 CID_85785449 | ||
| 0.061 | 0.022 | 0.061 | Glutamate (mGluR5) antagonist | |||
| 0.158 | 0.119 | 0.158 | Focal adhesion kinase 2 inhibitor | |||
| 0.081 | 0.043 | 0.082 | MAP kinase kinase 7 inhibitor | 0.082 0.04 CID_85785449 | CID_85785449 | |
| 0.09 | 0.051 | 0.098 | Granulocyte macrophage colony stimulating factor agonist | 0.098 0.038 CID_85785449 | CID_85785449 | |
| 0.077 | 0.039 | 0.077 | I kappa B kinase 1 inhibitor | |||
| 0.078 | 0.041 | 0.078 | Benzodiazepine agonist | |||
| 0.05 | 0.013 | 0.063 | Glucagon-like peptide 1 receptor antagonist | 0.063 0.008 CID_85785449 | CID_85785449 | |
| 0.06 | 0.024 | 0.06 | Adenosine A2b receptor antagonist | |||
| 0.079 | 0.044 | 0.079 | Protein kinase B beta inhibitor | |||
| 0.055 | 0.021 | 0.055 | Dopamine beta hydroxylase inhibitor | 0.052 0.027 CID_85785449 | ||
| 0.196 | 0.162 | 0.196 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.067 | 0.033 | 0.067 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.098 | 0.065 | 0.098 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.113 | 0.081 | 0.259 | Glutamate receptor antagonist | 0.259 0.014 CID_85785449 | CID_85785449 | |
| 0.073 | 0.041 | 0.073 | CDC7 inhibitor | |||
| 0.098 | 0.067 | 0.098 | Aurora-A kinase inhibitor | |||
| 0.077 | 0.047 | 0.077 | Adenosine A3 receptor antagonist | |||
| 0.07 | 0.041 | 0.07 | Potassium channel (ATP-sensitive) blocker | |||
| 0.095 | 0.066 | 0.109 | Platelet activating factor beta antagonist | 0.109 0.057 CID_115104 | CID_115104 | |
| 0.032 | 0.004 | 0.032 | Toll-Like receptor 8 agonist | 0.021 0.012 CID_85785449 | ||
| 0.031 | 0.003 | 0.031 | Granulocyte colony stimulating factor receptor agonist | 0.022 0.005 CID_115104 0.028 0.004 CID_85785449 | ||
| 0.04 | 0.013 | 0.04 | ATR kinase inhibitor | |||
| 0.084 | 0.058 | 0.121 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.121 0.024 CID_85785449 | CID_85785449 | |
| 0.051 | 0.026 | 0.051 | Thymidylate synthase inhibitor | 0.05 0.028 CID_85785449 | ||
| 0.1 | 0.075 | 0.1 | 5 Hydroxytryptamine 3A agonist | |||
| 0.06 | 0.037 | 0.06 | Fibroblast growth factor 4 antagonist | |||
| 0.089 | 0.066 | 0.089 | Antihistaminic | |||
| 0.091 | 0.068 | 0.148 | Platelet activating factor alpha antagonist | 0.148 0.031 CID_115104 | CID_115104 | |
| 0.032 | 0.01 | 0.032 | Corticotropin releasing factor 1 receptor antagonist | |||
| 0.057 | 0.035 | 0.057 | Bromodomain-containing protein 4 inhibitor | |||
| 0.1 | 0.078 | 0.1 | Glycogen synthase kinase-3 beta inhibitor | |||
| 0.08 | 0.059 | 0.08 | TIE antagonist | 0.073 0.067 CID_115104 | ||
| 0.078 | 0.06 | 0.078 | TIE-2 antagonist | 0.071 0.067 CID_115104 | ||
| 0.06 | 0.042 | 0.06 | Alpha 2 adrenoreceptor agonist | |||
| 0.022 | 0.005 | 0.022 | Prokineticin receptor 1 antagonist | |||
| 0.122 | 0.105 | 0.131 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.131 0.093 CID_85785449 | CID_85785449 | |
| 0.058 | 0.041 | 0.074 | Glutamate (mGluR1) antagonist | 0.074 0.027 CID_85785449 | CID_85785449 | |
| 0.067 | 0.051 | 0.067 | CDK1/cyclin B1 inhibitor | |||
| 0.025 | 0.008 | 0.025 | Histamine H4 receptor agonist | |||
| 0.032 | 0.016 | 0.032 | CDK4/cyclin D3 inhibitor | |||
| 0.092 | 0.076 | 0.237 | GABA C receptor agonist | 0.237 0.015 CID_85785449 | CID_85785449 | |
| 0.028 | 0.012 | 0.028 | Acid ceramidase inhibitor | |||
| 0.093 | 0.078 | 0.093 | Cyclin-dependent kinase 2 inhibitor | |||
| 0.079 | 0.064 | 0.079 | Histamine antagonist | |||
| 0.082 | 0.067 | 0.104 | Hematopoietic | 0.104 0.032 CID_85785449 | CID_85785449 | |
| 0.198 | 0.184 | 0.198 | Vasodilator, coronary | |||
| 0.069 | 0.054 | 0.069 | Polo-like kinase-2 inhibitor | |||
| 0.097 | 0.084 | 0.097 | Vascular endothelial growth factor antagonist | |||
| 0.062 | 0.049 | 0.062 | Interferon inducer | |||
| 0.065 | 0.053 | 0.079 | Glutamate (mGluR7) antagonist | 0.079 0.028 CID_85785449 | CID_85785449 | |
| 0.057 | 0.045 | 0.057 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.086 | 0.075 | 0.086 | MAP kinase 9 inhibitor | |||
| 0.125 | 0.115 | 0.125 | Pregnane X receptor agonist | |||
| 0.167 | 0.157 | 0.167 | 5 Hydroxytryptamine release stimulant | |||
| 0.052 | 0.042 | 0.052 | Pim-2 kinase inhibitor | |||
| 0.094 | 0.084 | 0.094 | Platelet activating factor antagonist | 0.09 0.089 CID_115104 | ||
| 0.099 | 0.091 | 0.099 | Cyclin-dependent kinase inhibitor | |||
| 0.013 | 0.004 | 0.013 | Corticotropin releasing factor antagonist | |||
| 0.087 | 0.08 | 0.087 | MAP kinase kinase kinase inhibitor | |||
| 0.077 | 0.071 | 0.077 | Insulin growth factor antagonist | |||
| 0.015 | 0.008 | 0.015 | 5 Lipoxygenase activating protein inhibitor | 0.014 0.01 CID_85785449 | ||
| 0.046 | 0.04 | 0.046 | Bromodomain-containing protein 3 inhibitor | |||
| 0.085 | 0.079 | 0.085 | Cyclin-dependent kinase 1 inhibitor | |||
| 0.088 | 0.082 | 0.107 | GABA C receptor rho-1 antagonist | 0.107 0.054 CID_85785449 | CID_85785449 | |
| 0.072 | 0.066 | 0.072 | Interferon agonist | |||
| 0.041 | 0.036 | 0.051 | AICAR transformylase inhibitor | 0.051 0.021 CID_85785449 | CID_85785449 | |
| 0.034 | 0.03 | 0.035 | Tryptophan 5 hydroxylase inhibitor | 0.035 0.027 CID_85785449 | CID_85785449 | |
| 0.085 | 0.081 | 0.085 | MAP kinase 8 inhibitor | |||
| 0.071 | 0.067 | 0.071 | Histamine H1 receptor antagonist | |||
| 0.047 | 0.043 | 0.047 | mTOR inhibitor | |||
| 0.129 | 0.126 | 0.136 | Heat shock protein 70 antagonist | 0.136 0.091 CID_85785449 | CID_85785449 | |
| 0.055 | 0.052 | 0.055 | Cyclin A2 inhibitor | |||
| 0.082 | 0.079 | 0.082 | Polo-like kinase-1 inhibitor | |||
| 0.047 | 0.045 | 0.047 | Toll-Like receptor 8 antagonist | |||
| 0.073 | 0.071 | 0.073 | Insulin like growth factor 1 antagonist | |||
| 0.034 | 0.032 | 0.034 | ATM kinase inhibitor | |||
| 0.034 | 0.033 | 0.034 | Cyclin D3 inhibitor | |||
| 0.119 | 0.118 | 0.119 | NOS3 expression enhancer | |||
| 0.1 | 0.099 | 0.1 | MAP kinase 12 inhibitor | |||
| 0.137 | 0.139 | 0.172 | Death-associated protein kinase 2 inhibitor | 0.172 0.065 CID_115104 | CID_115104 | |
| 0.087 | 0.091 | 0.16 | Protein kinase (CK2) alpha inhibitor | 0.16 0.036 CID_85785449 | CID_85785449 | |
| 0.128 | 0.132 | 0.136 | Ca2+-transporting ATPase inhibitor | 0.136 0.089 CID_85785449 | CID_85785449 | |
| 0.077 | 0.083 | 0.108 | NADH dehydrogenase inhibitor | 0.108 0.036 CID_85785449 | CID_85785449 | |
| 0.031 | 0.053 | 0.052 | Adenosine deaminase inhibitor | 0.052 0.028 CID_85785449 | CID_85785449 | |
| 0.084 | 0.107 | 0.104 | c-Src kinase inhibitor | 0.104 0.087 CID_115104 | CID_115104 | |
| 0.033 | 0.059 | 0.104 | AMPA receptor antagonist | 0.104 0.011 CID_85785449 | CID_85785449 | |
| 0.022 | 0.055 | 0.044 | Glutamate (mGluR group II) agonist | 0.044 0.018 CID_85785449 | CID_85785449 | |
| 0.028 | 0.061 | 0.038 | Acid-sensing ion channel blocker | 0.038 0.032 CID_115104 | CID_115104 | |
| 0.019 | 0.052 | 0.038 | Glutamate (mGluR2) agonist | 0.038 0.019 CID_85785449 | CID_85785449 | |
| 0.04 | 0.074 | 0.08 | Biliverdin reductase inhibitor | 0.08 0.026 CID_85785449 | CID_85785449 | |
| 0.197 | 0.232 | 0.429 | Antibacterial | 0.429 0.064 CID_85785449 | CID_85785449 | |
| 0.064 | 0.11 | 0.097 | HIV-1 integrase (Overall Integration) inhibitor | 0.097 0.057 CID_85785449 | CID_85785449 | |
| 0.115 | 0.171 | 0.151 | I kappa B kinase epsilon inhibitor | 0.151 0.119 CID_85785449 | CID_85785449 | |
| 0.044 | 0.102 | 0.109 | Glutamate receptor agonist | 0.109 0.032 CID_85785449 | CID_85785449 | |
| 0.217 | 0.279 | 0.34 | 5 Hydroxytryptamine release inhibitor | 0.34 0.124 CID_85785449 | CID_85785449 | |
| 0.109 | 0.174 | 0.13 | MAP kinase 3 inhibitor | 0.13 0.108 CID_115104 | CID_115104 | |
| 0.074 | 0.141 | 0.096 | Adenylate kinase inhibitor | 0.096 0.075 CID_85785449 | CID_85785449 | |
| 0.053 | 0.126 | 0.119 | Protein kinase (CK2) inhibitor | 0.119 0.049 CID_85785449 | CID_85785449 | |
| 0.031 | 0.104 | 0.081 | Aconitate hydratase inhibitor | 0.081 0.013 CID_85785449 | CID_85785449 | |
| 0.046 | 0.125 | 0.073 | Glutamate dehydrogenase inhibitor | 0.073 0.052 CID_85785449 | CID_85785449 | |
| 0.023 | 0.102 | 0.093 | Xanthine dehydrogenase inhibitor | 0.093 0.018 CID_85785449 | CID_85785449 | |
| 0.135 | 0.215 | 0.226 | Superoxide dismutase inhibitor | 0.226 0.092 CID_85785449 | CID_85785449 | |
| 0.027 | 0.109 | 0.051 | Argininosuccinate synthase inhibitor | 0.051 0.046 CID_85785449 | CID_85785449 | |
| 0.022 | 0.106 | 0.06 | AMPA 4 receptor antagonist | 0.06 0.01 CID_85785449 | CID_85785449 | |
| 0.013 | 0.097 | 0.06 | Nicotinic acid receptor agonist | 0.06 0.011 CID_85785449 | CID_85785449 | |
| 0.036 | 0.122 | 0.063 | Histidine decarboxylase inhibitor | 0.063 0.059 CID_85785449 | CID_85785449 | |
| 0.085 | 0.176 | 0.15 | Cell wall synthesis inhibitor | 0.15 0.066 CID_85785449 | CID_85785449 | |
| 0.063 | 0.155 | 0.089 | Electrolyte absorption antagonist | 0.089 0.075 CID_85785449 | CID_85785449 | |
| 0.005 | 0.1 | 0.035 | AMPA 1 receptor antagonist | 0.035 0.017 CID_85785449 | CID_85785449 | |
| 0.02 | 0.131 | 0.043 | Nicotinic acid receptor 1 agonist | 0.043 0.025 CID_85785449 | CID_85785449 | |
| 0.07 | 0.197 | 0.119 | Interleukin 4 antagonist | 0.119 0.087 CID_85785449 | CID_85785449 | |
| 0.007 | 0.159 | 0.028 | AMPA 3 receptor antagonist | 0.028 0.022 CID_85785449 | CID_85785449 | |
| 0.029 | 0.182 | 0.056 | DNA gyrase inhibitor | 0.056 0.055 CID_85785449 | CID_85785449 | |
| 0.049 | 0.246 | 0.103 | Alpha-N-acetylglucosaminidase inhibitor | 0.103 0.098 CID_85785449 | CID_85785449 | |
| 0.013 | 0.22 | 0.043 | NMDA receptor subunit 3B antagonist | 0.043 0.031 CID_85785449 | CID_85785449 | |
| 0.086 | 0.297 | 0.134 | Lipocortins synthesis antagonist | 0.134 0.132 CID_85785449 | CID_85785449 | |
| 0.008 | 0.223 | 0.035 | NMDA receptor subunit 3A antagonist | 0.035 0.03 CID_85785449 | CID_85785449 | |
| 0.042 | 0.257 | 0.088 | Xanthine oxidase inhibitor | 0.088 0.075 CID_85785449 | CID_85785449 | |
| 0.014 | 0.326 | 0.085 | NMDA receptor antagonist | 0.085 0.059 CID_85785449 | CID_85785449 | |
| 0.004 | 0.327 | 0.031 | Retinoid X gamma receptor agonist | 0.031 0.01 CID_85785449 | CID_85785449 | |
| 0.077 | 0.41 | 0.198 | Cholesterol antagonist | 0.198 0.167 CID_85785449 | CID_85785449 | |
| 0.005 | 0.343 | 0.109 | AMPA 2 receptor antagonist | 0.109 0.005 CID_85785449 | CID_85785449 | |
| 0.004 | 0.353 | 0.023 | Kainate receptor 3 antagonist | 0.023 0.007 CID_85785449 | CID_85785449 | |
| 0.004 | 0.412 | 0.046 | Kainate receptor 4 antagonist | 0.046 0.008 CID_85785449 | CID_85785449 | |
| 0.005 | 0.472 | 0.033 | Histone deacetylase 2 inhibitor | 0.033 0.024 CID_115104 | CID_115104 | |
| 0.003 | 0.515 | 0.035 | Kainate receptor 5 antagonist | 0.035 0.008 CID_85785449 | CID_85785449 | |
| 0.01 | 0.631 | 0.033 | ADAM10 endopeptidase inhibitor | 0.033 0.024 CID_115104 | CID_115104 | |
| 0.004 | 0.676 | 0.037 | Histone deacetylase class IIb inhibitor | 0.037 0.013 CID_115104 | CID_115104 | |
| 0.004 | 0.681 | 0.036 | Histone deacetylase 6 inhibitor | 0.036 0.013 CID_115104 | CID_115104 | |
| 0.009 | 0.708 | 0.108 | Uric acid excretion stimulant | 0.108 0.046 CID_85785449 | CID_85785449 | |
| 0.004 | 0.726 | 0.041 | Histone deacetylase class II inhibitor | 0.041 0.013 CID_115104 | CID_115104 | |
| 0.003 | 0.785 | 0.034 | Histone deacetylase 5 inhibitor | 0.034 0.022 CID_115104 | CID_115104 | |
| 0.004 | 0.789 | 0.047 | Nicotinic acid receptor 2 agonist | 0.047 0.015 CID_85785449 | CID_85785449 | |
| 0.003 | 0.843 | 0.027 | Histone deacetylase class IIa inhibitor | 0.027 0.025 CID_115104 | CID_115104 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |